维普期刊资源整合服务平台（V6.5）

2111篇 您的检索式：期刊名="Pharmacogenetics"

选中清除导出查看参考文献查看引证文献引用追踪共106页首页上一页第1页下一页末页 /106 跳转

	题名	作者	年代	出处	被引量
1	Expression of cytochrome P4502E1 CYP2E1 in human liver:assessment of mRNA,genotype and phenotype 显示文摘	Powell H Kitteringham NR Pirmohamed M	1998	Pharmacogenetics1998，8，：	2
2	Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans 显示文摘	Landi MT Bertazzi PA Shields PG	1994	Pharmacogenetics1994，4，：	2
3	Lung cancer risk in relation to the cyp2EI RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles Country显示文摘	London SJ Daly AK Cooper J	1996	Pharmacogenetics1996，6，：	2
4	Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment显示文摘	Elena De Mattia Giuseppe Toffoli Jerry Polesel Mario D’Andrea Giuseppe Corona Vittorina Zagonel Angela Buonadonna Eva Dreussi Erika Cecchin	2013	Pharmacogenetics and Genomics2013，，10：	2
5	The effect of CYP3A5 and MDR1(ABCB1)polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients显示文摘	Haufroid V Mourad M Van Kerckhove V	2004	Pharmacogenetics2004，14，3：	1
6	Human catechol-O-methyltransferase pharmacogenetics:description of a functional polymorphism and its potential application to neurospychiatric disorders显示文摘	LACHMAN HM PAPOLOS DF SAITO T	1996	Pharmacogenetics1996，6，3：	1
7	High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide2C (OATP2C , SLCO1B1) 显示文摘	Niemi M Schaeffeler E Lang T	2004	Pharmacogenetics2004，14，7：	1
8	p53polymorphic variants at codon72and the outcome of therapy in ran-domized breast cancer patients显示文摘	Wegman P Stal O Askmalm MS	2006	Pharmacogenet Ge-nomics2006，16，5：	1
9	The genetic determinants of the CYP 3A5 polymorphism显示文摘	Hustert E Haberl M Burk O	2001	Pharmacogenetics2001，11，9：	1
10	Response to infliximab treatment in Crohn' s disease is not associated with mutations in the CARD15 (NOD2) gene:an analysis in 534 patients from two multicenter prospective GCP-level trials显示文摘	Mascheretti S Hampe J Croucher PJ	2002	Pharmacogenetics2002，12，：	1
11	The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population显示文摘	ZHAI R LIU G YANG C	2001	Pharmacogenetics2001，11，：	1
12	Identification of the polymorphycally expressed CYP2C19 and the wild - type CYP2C19 - ILE359 allele as low- Km catalysts of cyclophosphamide and ifosfamide actication 显示文摘	Chang TK Yu L Goldstein JA	1997	Pharmacogenetics1997，7，：	1
13	S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians显示文摘	Persson I Aklillu E Rodrigues F	1996	Pharmacogenetics1996，6，：	1
14	Polymorphisms of the 5-HT2c receptor and leptin genes are associated with antipsychotie drug-induced weight gain in Caucasian subjects with a first-episode psychosis 显示文摘	Templeman LA Reynolds GP Arranz B	2005	Pharmacogenetics and Genomics2005，15，4：	1
15	Promoter polymorphisms and allelic imbalance in ABCB1 expression显示文摘	Loeuillet C Weale M Deutsch S et a1	2007	Pharmacogenet Genomics2007，17，：	1
16	Frequencies of the defec- tive CYP2C19 alleles responsible for the mephenytoin poor metaboli- zer phenotype in various Oriental, Caucasian, Sandi Arabian and A- merican black populations显示文摘	Goldstein JA Ishizaki T Chiba K	1997	Pharmacogenetics1997，7，：	1
17	Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral micro- dose and therapeutic dose 显示文摘	IEIRI I NISHIMURA C MAEDA K	2011	Pharmacogenet Genomics2011，21，8：	1
18	A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder显示文摘	McQuillin A Rizig M Gurling HM	2007	Pharmacogenet Genomics2007，17，8：	1
19	Genotype and phenotype of glutathione S-transferase mu in testieular cancer patients 显示文摘	Vistisen K Prieme H Okkels H	1997	Pharmacogenetics1997，7，1：	1
20	Hypothesis : comparisons of inter- and intra-individual variations can substitute for twin studies in drug research 显示文摘	Kalow W Tang BK Endrenyi L	1998	Pharmacogenetics1998，8，4：	1

返回顶部每页显示：

共106页首页上一页第1页下一页末页 /106 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示